NEW YORK, April 29, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum...

NEW YORK, April 28, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum...

NEW YORK, March 23, 2023 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a...

NEW YORK, March 23, 2023 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") today received a final award in the amount of...

NEW YORK, March 18, 2023 /PRNewswire/ -- Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar...

PR Newswire Fri, March 17, 2023 at 3:28 PM PDT·3 min read Announces its IND Submissions to FDA for Aquatox™ at the Annual American...

The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative...

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment...

NEW YORK, May 17, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") today announced that it has appointed Senior Vice...

Volume 19, No. 4 • April 2022

NEW YORK, March 24, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. announced today that it has submitted its IND package...

NEW YORK , March 21, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc ("Aquavit") continues to succeed in its intellectual property...

September 1, 2021; New York, NY Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a...

May 4, 2021; New York, NY U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for...

NEW YORK, April 14, 2021 Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize...

March 19, 2021: New York, NY Aquavit Pharmaceuticals, Inc. (“Aquavit”) announced today that the United States Patent and Trademark Office...

About Dr. Sten Vermund: Dr. Sten Vermund is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle...

April 15, 2021: New York, NY The European Union Intellectual Property Office (EUIPO) declared that U-BioMed’s falsely registered...

NEW YORK, Dec. 2, 2020 We are now living in the "new-normal" era, wearing face masks everywhere. With the extended use of face coverings,...